Plague Medication

  • Author: Vinod K Dhawan, MD, FACP, FRCP(C), FIDSA; Chief Editor: Russell W Steele, MD   more...
 
Updated: Aug 3, 2010
 

Antibiotic agents

Class Summary

Patients suspected to have plague should be promptly treated. Streptomycin or gentamicin are preferred. Doxycycline is an effective alternative. New multidrug-resistant strains of Y pestis have been reported in Madagascar.

View full drug information

Streptomycin

 

Aminoglycoside antibiotic is considered the drug of choice. Disadvantages include an intramuscular route of administration, resistant strains, and high toxicity.

View full drug information

Gentamicin (Garamycin)

 

Aminoglycoside used as an alternative to streptomycin and is equally effective.

View full drug information

Tetracycline (Sumycin)

 

Frequently used for prophylaxis as well as treatment. Is usually substituted for streptomycin after a few days of therapy to minimize toxicity. Inhibits bacterial protein synthesis by binding with 30S and, possibly, 50S ribosomal subunits.

View full drug information

Doxycycline (Doxy, Vibramycin)

 

Used as an alternative for tetracycline. Inhibits protein synthesis and thus bacterial growth by binding to 30S and, possibly, 50S ribosomal subunits.

View full drug information

Chloramphenicol (Chloromycetin)

 

DOC for plague meningitis. The PO form is not available in the United States, but the IV formulation can be obtained. Binds to 50S bacterial-ribosomal subunits and inhibits bacterial growth by inhibiting protein synthesis.

Proceed to Follow-up
 
 
Contributor Information and Disclosures
Author

Vinod K Dhawan, MD, FACP, FRCP(C), FIDSA  Professor, Department of Clinical Medicine, University of California, Los Angeles, David Geffen School of Medicine; Chief, Division of Infectious Diseases, Rancho Los Amigos National Rehabilitation Center

Vinod K Dhawan, MD, FACP, FRCP(C), FIDSA is a member of the following medical societies: American College of Physicians, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, Infectious Diseases Society of America, and Royal College of Physicians and Surgeons of Canada

Disclosure: Pfizer Inc Honoraria Speaking and teaching

Coauthor(s)

Robert D Schremmer, MD  Associate Professor, Department of Pediatrics, University of Missouri-Kansas City School of Medicine; Attending Physician, Division of Emergency Medical Services, Children's Mercy Hospital and Clinics

Robert D Schremmer, MD is a member of the following medical societies: Ambulatory Pediatric Association and American Academy of Pediatrics

Disclosure: Nothing to disclose.

Specialty Editor Board

José Rafael Romero, MD  Director of Pediatric Infectious Diseases Fellowship Program, Associate Professor, Department of Pediatrics, Combined Division of Pediatric Infectious Diseases, Creighton University/University of Nebraska Medical Center

José Rafael Romero, MD is a member of the following medical societies: American Academy of Pediatrics, American Society for Microbiology, Infectious Diseases Society of America, New York Academy of Sciences, and Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Leslie L Barton, MD  Professor Emerita of Pediatrics, University of Arizona College of Medicine

Leslie L Barton, MD is a member of the following medical societies: American Academy of Pediatrics, Association of Pediatric Program Directors, Infectious Diseases Society of America, and Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

Robert W Tolan Jr, MD  Chief, Division of Allergy, Immunology and Infectious Diseases, The Children's Hospital at Saint Peter's University Hospital; Clinical Associate Professor of Pediatrics, Drexel University College of Medicine

Robert W Tolan Jr, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, Phi Beta Kappa, and Physicians for Social Responsibility

Disclosure: Novartis Honoraria Speaking and teaching

Chief Editor

Russell W Steele, MD  Head, Division of Pediatric Infectious Diseases, Ochsner Children's Health Center; Clinical Professor, Department of Pediatrics, Tulane University School of Medicine

Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, and Southern Medical Association

Disclosure: Nothing to disclose.

References

  1. Butler T. Plague into the 21st century. Clin Infect Dis. Sep 1 2009;49(5):736-42. [Medline].

  2. Williamson ED. Plague. Vaccine. Nov 5 2009;27 Suppl 4:D56-60. [Medline].

  3. Prentice MB, Rahalison L. Plague. Lancet. Apr 7 2007;369(9568):1196-207. [Medline].

  4. Rocca P. The modern plague. Del Med J. May 2007;79(5):189-90. [Medline].

  5. Ben Ari T, Gershunov A, Gage KL, et al. Human plague in the USA: the importance of regional and local climate. Biol Lett. Dec 23 2008;4(6):737-40. [Medline].

  6. Thiagarajan B, Bai Y, Gage KL, Cully JF Jr. Prevalence of Yersinia pestis in rodents and fleas associated with black-tailed prairie dogs (Cynomys ludovicianus) at Thunder Basin National Grassland, Wyoming. J Wildl Dis. Jul 2008;44(3):731-6. [Medline].

  7. Eisen RJ, Enscore RE, Biggerstaff BJ, et al. Human plague in the southwestern United States, 1957-2004: spatial models of elevated risk of human exposure to Yersinia pestis. J Med Entomol. May 2007;44(3):530-7. [Medline].

  8. CDC. Human plague--four states, 2006. MMWR Morb Mortal Wkly Rep. Sep 1 2006;55(34):940-3. [Medline].

  9. Ben Ari T, Gershunov A, Gage KL, et al. Human plague in the USA: the importance of regional and local climate. Biol Lett. Sep 2 2008;[Medline].

  10. Cleri DJ, Vernaleo JR, Lombardi LJ, et al. Plague pneumonia disease caused by Yersinia pestis. Semin Respir Infect. Mar 1997;12(1):12-23. [Medline].

  11. World Health Organization. Human plague in 2002 and 2003. Wkly Epidemiol Rec. Aug 13 2004;79(33):301-6. [Medline].

  12. Gupta ML, Sharma A. Pneumonic plague, northern India, 2002. Emerg Infect Dis. Apr 2007;13(4):664-6. [Medline].

  13. Josko D. Yersinia pestis: still a plague in the 21st century. Clin Lab Sci. Winter 2004;17(1):25-9. [Medline].

  14. Neerinckx S, Bertherat E, Leirs H. Human plague occurrences in Africa: an overview from 1877 to 2008. Trans R Soc Trop Med Hyg. Feb 2010;104(2):97-103. [Medline].

  15. Human plague: review of regional morbidity and mortality, 2004-2009. Wkly Epidemiol Rec. Feb 5 2009;85(6):40-5. [Medline].

  16. Cornelius C, Quenee L, Anderson D, Schneewind O. Protective immunity against plague. Adv Exp Med Biol. 2007;603:415-24. [Medline].

  17. Crook LD, Tempest B. Plague. A clinical review of 27 cases. Arch Intern Med. Jun 1992;152(6):1253-6. [Medline].

  18. Dattwyler RJ. Community-acquired pneumonia in the age of bio-terrorism. Allergy Asthma Proc. May-Jun 2005;26(3):191-4. [Medline].

  19. Dennis DT, Chow CC. Plague. Pediatr Infect Dis J. Jan 2004;23(1):69-71. [Medline].

  20. Hoyle JD Jr, White LJ. Treatment of pediatric and adolescent mental health emergencies in the United States: current practices, models, barriers, and potential solutions. Prehosp Emerg Care. Jan-Mar 2003;7(1):66-73. [Medline].

  21. Laudisoit A, Leirs H, Makundi RH, Van Dongen S, Davis S, Neerinckx S, et al. Plague and the human flea, Tanzania. Emerg Infect Dis. May 2007;13(5):687-93. [Medline].

  22. Ligon BL. Plague: a review of its history and potential as a biological weapon. Semin Pediatr Infect Dis. Jul 2006;17(3):161-70. [Medline].

  23. Mittal V, Bhattacharya D, Rana UV, Rai A, Pasha ST, Kumar A, et al. Prompt laboratory diagnosis in timely containment of a plague outbreak in India. J Commun Dis. Dec 2006;38(4):317-24. [Medline].

  24. Russell P, Nelson M, Whittington D, et al. Laboratory diagnosis of plague. Br J Biomed Sci. Dec 1997;54(4):231-6. [Medline].

  25. Smego RA, Frean J, Koornhof HJ. Yersiniosis I: microbiological and clinicoepidemiological aspects of plague and non-plague Yersinia infections. Eur J Clin Microbiol Infect Dis. Jan 1999;18(1):1-15. [Medline].

  26. Solomon T. Hong Kong, 1894: the role of James A Lowson in the controversial discovery of the plague bacillus. Lancet. Jul 5 1997;350(9070):59-62. [Medline].

  27. Tomaso H, Jacob D, Eickhoff M, et al. Preliminary validation of real-time PCR assays for the identification of Yersinia pestis. Clin Chem Lab Med. 2008;46(9):1239-44. [Medline].

  28. Weir E. Plague: a continuing threat. CMAJ. Jun 7 2005;172(12):1555. [Medline].

 
Previous
Next
 
Male Xenopsylla cheopis (oriental rat flea) engorged with blood. This flea is the primary vector of plague in most large plague epidemics in Asia, Africa, and South America. Both male and female fleas can transmit the infection. Image courtesy of the Centers for Disease Control and Prevention (CDC).
Wright stain peripheral blood smear of patient with septicemic plague demonstrating bipolar, safety pin staining of Yersinia pestis. Although Wright stain often demonstrates this characteristic appearance, Giemsa and Wayson stains most consistently highlight this pattern. Courtesy of Jack Poland, PhD, Centers for Disease Control and Prevention (CDC), Fort Collins, CO.
Inguinal bubo on upper thigh of a person with bubonic plague. Image courtesy of the Centers for Disease Control and Prevention (CDC).
Yersinia pestis bacteria on fluorescent antibody test. Image courtesy of the Centers for Disease Control and Prevention (CDC).
World distribution of plague, 1998. From the Centers for Disease Control and Prevention (CDC), Atlanta, Ga.
Pictured is a flea with a blocked proventriculus, which is equivalent to the gastroesophageal region in a human. In nature, this flea would develop a ravenous hunger because of its inability to digest the fibrinoid mass of blood and bacteria. If this flea were to bite a mammal, the proventriculus would be cleared, and thousands of bacteria would be regurgitated into the bite wound. Courtesy of the United States Army Environmental Hygiene Agency.
After the femoral lymph notes, the next most commonly involved regions in plague are the inguinal, axillary, and cervical areas. This child has an erythematous, eroded, crusting, necrotic ulcer at the presumed primary inoculation site in the left upper quadrant. This type of lesion is uncommon in patients with plague. The location of the bubo is primarily a function of the region of the body in which an infected flea inoculates plague bacilli. Courtesy of Jack Poland, PhD, Centers for Disease Control and Prevention (CDC), Fort Collins, Colo.
Ecchymoses at the base of the neck in a girl with plague. The bandage is over the site of a prior bubo aspirate. These lesions are probably the source of the line from the children's nursery rhyme, "ring around the rosy." Courtesy of Jack Poland, PhD, Centers for Disease Control and Prevention (CDC), Fort Collins, Colo.
Acral necrosis of the nose, the lips, and the fingers and residual ecchymoses over both forearms in a patient recovering from bubonic plague that disseminated to the blood and the lungs. At one time, the patient's entire body was ecchymotic. Reprinted from Textbook of Military Medicine. Washington, DC, US Department of the Army, Office of the Surgeon General, and Borden Institute. 1997:493. Government publication, no copyright on photos.
Acral necrosis of the toes and residual ecchymoses over both forearms in a patient recovering from bubonic plague that disseminated to the blood and the lungs. At one time, the patient's entire body was ecchymotic. Reprinted from Textbook of Military Medicine. Washington, DC: US Department of the Army, Office of the Surgeon General, and Borden Institute. 1997:493. Government publication, no copyright on photos.
Rock squirrel in extremis coughing blood-streaked sputum related to pneumonic plague. Courtesy of Ken Gage, PhD, Centers for Disease Control and Prevention (CDC), Fort Collins, Colo.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.